Publish Date: August 2026
Updated Tariff & Recession Risk Analysis and Forecasts
The 2026 Pharmaceutical Manufacturing Market Report covers the $339.9 billion industry which develops and produces medications and biological products addressing human and animal health needs. Competitive structure encompasses global research-based pharmaceutical corporations alongside specialized manufacturers focused on particular therapeutic areas or technologies. Market demands increasingly emphasize demonstrated efficacy, safety profiles, pricing justification, and manufacturing quality assurance addressing heightened regulatory requirements. Manufacturers face challenges balancing research and development investments, regulatory compliance, intellectual property protection, and tariff considerations affecting both ingredient imports and international market access. Successful companies establish advantages through innovative molecule discovery creating medical advances, specialized development capabilities advancing clinical applications, operational excellence ensuring consistent quality, and increasingly patient-focused delivery systems enhancing therapeutic outcomes in a highly regulated sector where both scientific capabilities and operational reliability critically determine competitive positioning.
Pharmaceutical Manufacturing Industry Description
Pharmaceutical Manufacturing develops and produces medications and biological treatments for human and animal health applications. Companies discover, test, and manufacture active pharmaceutical ingredients and finished drug products through complex chemical and biological processes. Manufacturing processes include chemical synthesis, fermentation, extraction, purification, formulation, and specialized packaging operations conducted under strictly controlled conditions. These businesses serve healthcare systems with treatments for disease prevention and management. The industry operates under extensive regulatory oversight, continuously improving manufacturing precision, quality control, and increasingly focusing on targeted therapies, biologics, and manufacturing technologies that enhance drug efficacy and safety.
NAICS Code: 3254
Number of Companies: 1,844
Number of Plants / Facilities: 2,278
Total Employees: 301,359
Market Size: $339.9 billion
TARIFF IMPACT (Summer 2025 – Download Report for Updated Analysis)
This report has in-depth analysis on the recent US tariff changes on material costs, quantifying import dependencies, tariff exposure rates, and key source countries for the pharmaceutical manufacturing sector.
Estimated Tariff Cost: $4.9 billion
Relative Tariff Impact: MODERATE
Pharmaceutical Manufacturing Report Format
The 2026 U.S. Pharmaceutical Manufacturing Market Report is 63 pages of deep insights into the trends, dynamics, and forecasts shaping the industry. This market report is utilized by professionals to gain a in-depth understanding of the sector for business strategy, planning, forecasting, benchmarking, industry analysis, valuations, identifying organizational inefficiencies, financial analysis, and more.
This report covers more than 100 statistical data sets with historical trend data from 2017 to 2025, and 2026 and 2030 forecasts. The report includes revenue & cost trends, 26 expense categories, dozens of financial metrics, extensive forecasts, inventory trends & analysis, detailed breakdown of 31 balance sheet items, numerous industry segmentations, competitive intensity analysis, production material costs, profitability metrics, state metrics analysis, plant capacity analysis, employee role analysis, 4 years of inflation analysis, wage analysis, revenue per employee trends, and more.
Below are a few page images from the report and check out the table of contents for a complete overview.
Report Table of Contents
Explore the below table of contents to understand the comprehensive insights in the report and why thousands of professionals and executives count on Kentley Insights for their industry research.
The sources for the report data include federal and private surveys completed by the majority of companies in the sector covering extensive financial and operational topics for the pharmaceutical manufacturing industry. The forecasts in the report are modeled by our research analysts using the latest economic forecasts, industry analysis, and historical trends.
1-2 – Market Report Overview & Contents
3 – Market Overview
– Data Sources, Industry Definition & Market Commentary
4 – Market Synopsis – Revenue & Growth
5 – Market Synopsis – Costs & Profitability
SECTION ONE
REVENUE & GROWTH ANALYSIS
7 – Market Size Details
– Industry Revenues, Companies & Facilities
– Trend Analysis 2017-2025
– 2026 & 2030 Forecasts
8 – Growth Benchmarks
– Sales per Company & Plant
– Trend Analysis 2017-2025
– 2026 & 2030 Forecasts
9 – Product Lines Revenue
– Percentage of Revenue from Product Lines
10 – BCG Matrix – Net Income vs. Revenue Growth
– Subsectors vs. Industry
11 – Total Sales by Month & Year
– 2021-2025 Sales per Month
12 – Inventory Value by Month & Year
– Inventory Value per Month for 2021-2025
13 – Months of Inventory
– Months of Inventory per Month for 2021-2025
14 – Sector Revenue by Segments
– Concentration Segments by Top Companies
– Business Size Segments
– Business Structure Segments
15 – Market Size by State
16 – Market Size as a % of State GDP
17 – Sales as a % of State Manufacturing
18 – Market Segmentation by Business Size
19 – Market Segmentation by Business Size
– Business Size Segments – 1-4, 5-9, 10-20, 21-50, 51-100, 101-250, & 250+ employees
– Companies, Facilities, Sales, Employees & Payroll
20 – Segmentation by Concentration (Top 50 Companies)
– Concentration Segments – Top 4, 5-8, 9-20, & 21-50 companies
– Companies, Facilities, Sales, Employees & Payroll
21 – Market Share of Top 50 Companies
22 – Subsector Market Share of Top 50 Companies
23 – Segmentation by Business Structure
– Business Structure Segments – C-Corporations, S-Corporations, Partnerships, & Sole Proprietorships
– Companies, Facilities, Sales, Employees & Payroll
24 – Revenue per Company by State
– Revenue per Company
25 – Revenue per Company by Segments
26 – Revenue per Facility by State
27 – Revenue per Facility by Segment
– Business Size, Concentration, & Structure
28 – Subsector Growth
– Sales and 5-Year Growth
29 – Subsector Statistics
– Sales per Company & Facility, and 5-Year Growth
30 – Consolidation Analysis
– 5-Year Growth of Companies & Locations
31 – Employment Consolidation Analysis
– 5-Year Growth of Employee Statistics
32 – Subsector Consolidation Analysis
– Number of Companies & Facilities
– 5-Year Growth
33 – Subsector Consolidation Analysis
– Facilities per Company
– Employees per Company
– 5-Year Growth
SECTION TWO
COST, CAPITAL & PROFIT BENCHMARKS
35 – Profitability & Financial Ratio Analysis
– Percent of Companies that are Profitable
– Average Net Income as a Percent of Revenue
– 10 of the Top Financial Ratios
– Assets and Liabilities indexed to industry revenue at 100
– Current & Non-Current Assets: 14 Categories
– Short-term, Long-term Liabilities, & Net Worth: 13 Categories
37 – OPEX
– Industry OPEX
– Revenue vs. OPEX Growth
– OPEX as a Percent of Revenue
– Trend Analysis 2017-2025
– 2026 & 2030 Forecasts
38 – OPEX by Company & Plant
– OPEX per Company & Facility
– Revenue vs. Expenses Growth per Plant
– Trend Analysis & Forecasts
Page 39 – OPEX Detail
– Employee Expenses: payroll, insurance, pension, defined contribution plans, fringe benefits, temps
– Cost of Materials: materials, parts, containers, packaging, cost of resale, electricity and fuels, contract work
– Buildings and Equipment: capex for equipment, rental or lease for equipment, capex for buildings and structures, rental or leases, repair and maintenance
– Other Operating Expenses: professional and technical services, IT software and hardware, data processing and communications, advertising, refuse removal, taxes and license fees, other
-Inventory Breakdown: finished goods, work-in-progress, materials and supplies
40 – Production Material Costs & Tariff Analysis
– Top Production Material Costs Breakdown
– Industry & Material Tariff Analysis – % of costs, import %, tariff costs, source countries
41 – Producer Pricing Index
– Annual PPI – Indexed to 2006
– Trend Analysis & Forecasts
– Monthly PPI Figures for the Past 4 Years
42 – Plant Utilization & Hours
– Plant Utilization Rate
– Plant Operational Hours per Week
– 2022-2025 Historical Figures by Quarter
43 – Reasons for Non-Full Production
– 7 Categories Quarterly Survey Results for Past 2 Years
44 – Productivity & Employment
– Revenue per Employee
– Total Employees
– Employees per Company
– Trend Analysis & Forecasts
45 – Employee Productivity by Segments
– Business Size, Concentration, & Structure
46 – Employee Productivity by State
47 –Subsector Sales & Payroll per Employee
– Absolute & 5-Year Growth
48 – Payroll Analysis
– Payroll per Employee, Company & Plant
– Trend Analysis & Forecasts
49 – Payroll per Company by Segments
50 – Payroll per Plant by Segments
51 – Payroll per Employee by Segments
52 – Payroll per Employee by State
53 – Organizational Composition
– % of Employees for 27 Job Categories
– Management & Finance
– Sales & Marketing
– Technology, Engineering, Science
– Service, Support & Training
– Operations
54 – Job Categorization Pay Ranges
– Management & Finance
– Sales, Service & Marketing
– Operations
– Pay Bands – Bottom 10% & 25%, Mean, Top 25% & 10%
55 – Top 20 Jobs Breakdown
56 – Top 20 Jobs Pay
57 – Employees per Company by Segments
58 – Employees per Plant by Segments
59 – Facilities per Company by Segments
60 – Total Employment by State
61 – Population to Every Employee by State
62 – Employees per Facility by State
63 – Overview of Kentley Insights
Download a Sample Report
Below is a free sample report download. The 2026 Pharmaceutical Manufacturing Market Report has the same layout and data sets as the sample report.
Product Lines, Materials, and Jobs Covered in Report
PRODUCT LINES
Pharmaceutical preparation manufacturing
Biological product (except diagnostic) manufacturing
Medicinal and botanical manufacturing
In-vitro diagnostic substance manufacturing
MATERIAL COST CATEGORIES
Pharmaceuticals & medicines, including synthetic; medicinal & botanical drugs, chemicals, and products; biological products; etc.
Materials, ingredients, containers, and supplies, nsk
Cost of all other materials and components, parts, containers, and supplies consumed
All basic organic and inorganic chemicals, excluding petrochemicals
Plastics products (including packaging, foam products, film, sheet, rod, tube, fabricated shapes, bottles, etc.)
Plastics containers (including bottles, jars, tubes, tubs, etc.)
Paper and paperboard products
Glass and glass products
Agricultural products (crude), including flowers, grains, seeds, herbs, etc.
Metal containers, cans, lids, ends, and parts
INDUSTRY JOBS ANALYZED
Packaging and Filling Machine Operators and Tenders
Chemists and Materials Scientists
Sales Representatives, Wholesale and Manufacturing
Chemical Processing Machine Setters, Operators, and Tenders
Inspectors, Testers, Sorters, Samplers, and Weighers
Crushing, Grinding, Polishing, Mixing, and Blending Workers
First-Line Supervisors of Production and Operating Workers
Medical Scientists
Biological Scientists
Laborers and Material Movers, Hand
Industrial Engineers, Including Health and Safety
Industrial Machinery Installation, Repair, and Maintenance Workers
Chemical Technicians
Industrial Production Managers
Biological Technicians
General and Operations Managers
Natural Sciences Managers
Miscellaneous Business Operations Specialists
Secretaries and Administrative Assistants
Miscellaneous Assemblers and Fabricators
About Kentley Insights
All the top consulting firms, banks, accounting firms, private equity firms, and many of the Fortune 1000 depend on Kentley Insights for their in-depth market research needs.
Purchase the 2026 U.S. Pharmaceutical Manufacturing Market Report to unlock the 63 pages of data-rich insights backed by our 100% MoneyBack Guarantee.
Support Contact:
Email us at support@kentleyinsights.com
Call us at 1-800-613-3611